We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack (377572)

ARTG ID 377572

ARTG Name

PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack

Product name

PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack

ARTG Date

20 January 2022

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

nirmatrelvir

ritonavir

Licence category

RE

Licence status

A

Summary

Product information

Consumer medicine information

Related information

PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack, Pfizer Australia Pty Ltd, CON-1178

14 November 2023

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 14 November 2023 until 30 June 2024.
PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack, Pfizer Australia Pty Ltd, CON-908

18 January 2022

Section 14 consent

Consent to Import and supply while noncompliant with standards. The consent is effective for all batches released for supply from 18 January 2022 until 18 January 2024.
PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack, Pfizer Australia Pty Ltd, CON-925

20 April 2022

Section 14 consent

Consent to Import and supply while noncompliant with standards. The consent is effective for all batches released for supply from the 20 April 2022 until 18 January 2024.